Clinical trial
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating…
NCT00262821 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00262821 |
|---|---|
| Title | Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer |
| Official title | A Phase III, Randomized Trial of Weekly Cisplatin and Radiation Versus Cisplatin and Tirapazamine and Radiation in Stage IB2, IIA, IIIB and IVA Cervical Carcinoma Limited to the Pelvis |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | NCIC Clinical Trials Group Gynecologic Oncology Group |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, tirapazamine |
| Enrollment | 402 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Dec 7, 2005 |
| Last update posted | Jul 23, 2019 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: